Quinoline-8-D - CAS 15793-87-0
Catalog: |
BB011372 |
Product Name: |
Quinoline-8-D |
CAS: |
15793-87-0 |
Synonyms: |
quinoline; quinoline |
IUPAC Name: | quinoline |
Description: | Quinoline-8-D (CAS# 15793-87-0 ) is a useful research chemical. |
Molecular Weight: | 130.16 |
Molecular Formula: | C9H6ND |
Canonical SMILES: | C1=CC=C2C(=C1)C=CC=N2 |
InChI: | InChI=1S/C9H7N/c1-2-6-9-8(4-1)5-3-7-10-9/h1-7H |
InChI Key: | SMWDFEZZVXVKRB-UHFFFAOYSA-N |
Boiling Point: | 460 °F at 760 mmHg| |
Melting Point: | 5 °F |
Flash Point: | 138 °F |
Density: | 1.095 at 68 °F |
Solubility: | 12.4 [ug/mL] (The mean of the results at pH 7.4) |
Appearance: | Colorless liquid |
Decomposition: | When heated to decomposition it emits toxic fumes of /nitrogen oxides |
LogP: | 2.23480 |
pH: | Weak tertiary base |
Stability: | Darkens on storage in ordinary, Stoppered bottle |
Vapor Pressure: | 1 mmHg at 139.5 °F ; 5 mmHg at 193.3 °F |
GHS Hazard Statement: | H302: Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P201, P202, P264, P270, P273, P280, P281, P301+P312, P302+P352, P305+P351+P338, P308+P313, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P391, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
US-10962529-B1 | Fluorescent probe based biosensor and assay for the detection of SARS-CoV-2 | 20201201 |
US-10975102-B1 | Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitumor agents | 20200921 |
US-11028300-B1 | Environmentally friendly refrigerant compositions | 20200916 |
US-10902974-B1 | Transparent conductive film | 20200731 |
US-10882852-B1 | 3-vinylquinolines as cancer cells inhibitors | 20200709 |
PMID | Publication Date | Title | Journal |
34058295 | 20210630 | Computational and experimental studies on the inhibitory mechanism of hydroxychloroquine on hERG | Toxicology |
32969660 | 20201022 | Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) | Journal of medicinal chemistry |
31836637 | 20200201 | Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against Plasmodium falciparum | Molecular & cellular proteomics : MCP |
31638783 | 20191118 | Repurposing of Nitroxoline Drug for the Prevention of Neurodegeneration | Chemical research in toxicology |
31022492 | 20190615 | HHQ-4, a quinoline derivate, preferentially inhibits proliferation of glucose-deprived breast cancer cells as a GRP78 down-regulator | Toxicology and applied pharmacology |
Complexity: | 111 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 129.057849228 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 129.057849228 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 12.9 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoline/Isoquinoline
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS